- 询价
- 辰辉创聚生物
- 中国
- NBL-242191
- 2025年06月30日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Short term 4℃; Long term -20℃.
- 保质期：
见COA
- 英文名：
Recombinant Human PLA2G1B, hFc-tag
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 规格：
100ug;1mg;Bulk
| 产品信息
品名:NebuSelect™ Recombinant Human PLA2G1B, hFc-tag
货号:NBL-242191
品牌:Nebulabio
规格:100ug；1mg；Bulk
| 产品描述
NebuSelect™ Recombinant Human PLA2G1B, hFc-tag(Cat#NBL-242191) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Ala23-Ser148.
| 产品属性
表达系统:HEK293
标签:hFc-tag
靶点名称:PLA2G1B
物种：Human
分子量：The protein has a predicted MW of 40.9 kDa. Due to glycosylation, the protein migrates to 50-55 kDa based on Bis-Tris PAGE result.
氨基酸序列：Ala23-Ser148
Accession: P04054
纯度:＞95%
内毒素：＜1EU/ug(LAL Method)
储存运输条件: Short term 4℃; Long term -20℃.
| 靶点信息
Phospholipase A2 (PLA2) plays crucial roles in diverse cellular responses, including phospholipid digestion and metabolism, host defense and signal transduction. PLA2 provides precursors for generation of eicosanoids, such as prostaglandins (PGs) and leukotrienes (LTs), when the cleaved fatty acid is arachidonic acid, platelet-activating factor (PAF) when the sn-1 position of the phosphatidylcholine contains an alkyl ether linkage and some bioactive lysophospholipids, such as lysophosphatidic acid (lysoPA).
For Research Use Only!
To get more information, please contact us freely.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验也可以从其他物种中去除白蛋白。适用于处理 25 或 50 个样本。Figure 1: 2D analysis of whole human serum before (left) and after(right) treatment with AlbminOUT™. 产品特点： ● 从样本中不到 10 分钟的时间内去除白蛋白 ● 基于白蛋白和 Cibachron 蓝色染料的结合 ● 每个柱子的结合力大于 2 mg 的人白蛋白 ● 从 5-50
) in any given fraction have relevance to any human disease? If the protein has no obvious use as a drug target, it is ignored. If the protein is deemed relevant, one immediately has a lead molecule and a defined target. In cases where a single protein is eluted
标记（peptide tag）的使用，可能会因为空间效应影响蛋白的结合区而使蛋白无法结合；最后，NAPPA的蛋白体外表达系统缺乏后翻译的修饰（posttranslational modification），也会因为无法满足体内蛋白表达的时间和空间的分隔，导致蛋白的折叠和活性的变化。无论如何，NAPPA的出现，给生产蛋白芯片提供了更多的途径，是一个令人鼓舞的重大突破。 Science, Vol 305, Issue 5680, 86-90 , 2 July 2004 Self-Assembling
技术资料暂无技术资料 索取技术资料
